山西擬將黨蔘片及當歸等21種中藥飲片列入帶量採購清單
據《澎湃新聞》報道,山西省藥械集中招採中心公佈,按照三明採購聯盟(全國)辦公室《關於開展部份中藥飲片品種相關數據填報工作的通知》要求,組織山西省醫療機構開展中藥飲片集中帶量採購相關品種採購數據填報工作通知。
根據山西公佈中藥飲片聯合帶量採購品種清單,此次集採報量涉及21箇中藥飲片品種,包括黨蔘片、金銀花、當歸、天麻、麥冬、太子參、白芍、甘草片、山藥、蒲公英、牡丹皮及桔梗等。(ta/w) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.